Cargando…

Quality assurance in human papillomavirus testing for primary cervical screening

The recommendation for cervical screening is that it should be based on human papillomavirus (HPV) molecular testing. For all screening programs, attention to quality assurance is required to fully realize the benefits. Internationally recognized quality assurance recommendations for HPV-based scree...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cuschieri, Kate, Fellner, María Dolores, Arroyo Mühr, Laila Sara, Padalko, Elizaveta, Correa, Rita Mariel, Dillner, Joakim, Gultekin, Murat, Picconi, Maria Alejandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176393/ https://www.ncbi.nlm.nih.gov/pubmed/36914171 http://dx.doi.org/10.1136/ijgc-2022-004197

Ejemplares similares

Human Papillomavirus Detection by Whole-Genome Next-Generation Sequencing: Importance of Validation and Quality Assurance Procedures
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2021)

Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2022)

Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2020)

Human papillomavirus type 16 genomic variation in women with subsequent in situ or invasive cervical cancer: prospective population-based study
por: Arroyo-Mühr, Laila Sara, et al.
Publicado: (2018)

Deep sequencing extends the diversity of human papillomaviruses in human skin
por: Bzhalava, Davit, et al.
Publicado: (2014)

Metatranscriptome analysis in human papillomavirus negative cervical cancers
por: Ure, Agustin Enrique, et al.
Publicado: (2022)

Head-to-Head Comparison of Bi- and Nonavalent Human Papillomavirus Vaccine-Induced Antibody Responses( )
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2022)

Human papillomavirus genotyping using next generation sequencing (NGS) in cervical lesions: Genotypes by histologic grade and their relative proportion in multiple infections
por: Basiletti, Jorge Alejandro, et al.
Publicado: (2022)

HPV transcription in skin tumors
por: Hultin, Emilie, et al.
Publicado: (2019)

Comparison of DNA and RNA sequencing of total nucleic acids from human cervix for metagenomics
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2021)

Validation of the cobas 6800 human papillomavirus test in primary cervical screening
por: Sundström, Karin, et al.
Publicado: (2021)

Using HPV-meta for human papillomavirus RNA quality detection
por: Ure, Agustin, et al.
Publicado: (2022)

Distribution of human papillomavirus genotypes by severity of cervical lesions in HPV screened positive women from the ESTAMPA study in Latin America
por: Correa, Rita Mariel, et al.
Publicado: (2022)

Viruses in case series of tumors: Consistent presence in different cancers in the same subject
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2017)

Mapping HPV 16 Sub-Lineages in Anal Cancer and Implications for Disease Outcomes
por: Guerendiain, Daniel, et al.
Publicado: (2022)

De novo sequence assembly requires bioinformatic checking of chimeric sequences
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2020)

Are vaginal swabs comparable to cervical smears for human papillomavirus DNA testing?
por: Coorevits, Liselotte, et al.
Publicado: (2018)

European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination
por: von Karsa, Lawrence, et al.
Publicado: (2015)

Comparative effectiveness study on human papillomavirus detection methods used in the cervical cancer screening programme
por: Nygård, Mari, et al.
Publicado: (2014)

Detection of DNA viruses in prostate cancer
por: Smelov, Vitaly, et al.
Publicado: (2016)

Corrigendum: Detection of DNA viruses in prostate cancer
por: Smelov, Vitaly, et al.
Publicado: (2016)

Impact of cervical screening by human papillomavirus genotype: Population-based estimations
por: Wang, Jiangrong, et al.
Publicado: (2023)

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening
por: Ejegod, Ditte Møller, et al.
Publicado: (2020)

A comprehensive HPV-STI NGS assay for detection of 29 HPV types and 14 non-HPV sexually transmitted infections
por: Ma, Zhihai, et al.
Publicado: (2022)

Human papillomavirus genotype-specific risks for cervical intraepithelial lesions
por: Nygård, Mari, et al.
Publicado: (2020)

Organized primary human papillomavirus–based cervical screening: A randomized healthcare policy trial
por: Elfström, K. Miriam, et al.
Publicado: (2021)

Assessment of bacterial and viral gut communities in healthy and tumoral colorectal tissue using RNA and DNA deep sequencing
por: Garcia‐Serrano, Ainhoa, et al.
Publicado: (2023)

The Launch of an International Animal Papillomavirus Reference Center
por: Van Doorslaer, Koenraad, et al.
Publicado: (2019)

Duplex realtime PCR method for Epstein–Barr virus and human DNA quantification: its application for post-transplant lymphoproliferative disorders detection
por: Fellner, María Dolores, et al.
Publicado: (2014)

Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer
por: Lagheden, Camilla, et al.
Publicado: (2018)

Human papillomavirus genotype distribution in cervical cancer biopsies from Nepalese women
por: Sah, Sunil Kumar, et al.
Publicado: (2018)

Laboratory and clinical aspects of human papillomavirus testing
por: Chan, Paul K.S., et al.
Publicado: (2012)

Patterns of Human Papillomavirus Types in Multiple Infections: An Analysis in Women and Men of the High Throughput Human Papillomavirus Monitoring Study
por: Vaccarella, Salvatore, et al.
Publicado: (2013)

Differences in risk for SARS-CoV-2 infection among healthcare workers
por: Elfström, K. Miriam, et al.
Publicado: (2021)

Targeting Human Papillomavirus to Reduce the Burden of Cervical, Vulvar and Vaginal Cancer and Pre-Invasive Neoplasia: Establishing the Baseline for Surveillance
por: Nygård, Mari, et al.
Publicado: (2014)

Expressed Prostate Secretions in the Study of Human Papillomavirus Epidemiology in the Male
por: Smelov, Vitaly, et al.
Publicado: (2013)

Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC)
por: Kyrgiou, Maria, et al.
Publicado: (2020)

High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study
por: Lei, Jiayao, et al.
Publicado: (2018)

Human papillomavirus types in cervical high‐grade lesions or cancer among Nordic women—Potential for prevention
por: Dovey de la Cour, Cecilie, et al.
Publicado: (2019)

Assessing the detection of human papillomavirus late mRNA in liquid base cytology samples for risk stratification of cervical disease
por: Chambers, George, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_j39lvtdcsun94ubn2sdc8kur7u